India's pharmaceutical market rose 7.3% year-on-year in September to ₹20,886 crore, driven by robust growth in antidiabetic, ...
By Dennis Thompson HealthDay ReporterMONDAY, Oct. 6, 2025 (HealthDay News) — An approved pill for Alzheimer’s disease might ...
Ginger water offers health benefits but can cause side effects. Excessive intake may lead to digestive issues like bloating ...
Irish Examiner on MSN
Cork operations of Eli Lilly underpin Ozempic maker Novo Nordisk's dwindling market dominance
With Cork a crucial part of its global supply chain, Eli Lilly's weight loss drugs are shaking up an industry once ruled by ...
The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has opined that Novo Nordisk ...
Biomea Fusion shares spiked on positive 52-week Phase II data for icovamenib in type 2 diabetes. Read why I rate BMEA stock a ...
India’s anti-obesity pharmaceutical market is valued at ₹859 crore, having recorded a five-fold increase over five years with ...
Amy Schumer has stepped out showing off her trimmed down figure. The US comedian, 44, was spotted out for a stroll in New ...
A statewide probe in Rajasthan has uncovered massive lapses in drug regulation, revealing that substandard and fake medicines ...
Eli Lilly's weight-loss drug Mounjaro is rapidly climbing the ranks in the Indian pharmaceutical market, nearing ...
Newspoint on MSN
Fake Antibiotics & Painkillers Flood Rajasthan Market: Probe Reveals Wide-Scale Spurious Drug Crisis
A silent health crisis is unfolding in Rajasthan. Hundreds of medicines failed quality tests, many after reaching patients.
Icovamenib showed a sustained treatment benefit at Week 52 (9 months past the end of treatment) in the severe insulin-deficient diabetes patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback